Drug Costs Archives - Page 28 of 35

Enrollment 2018

Podcast: KHN’s ‘What The Health?’ There’s A Really Big Health Bill In That Budget Deal

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss the health policy changes included in the just-concluded bipartisan budget deal on Capitol Hill. The panelists also talk about the final enrollment numbers for individual insurance purchased under the Affordable Care Act, and possible drug price proposals in President Donald Trump’s upcoming budget. Plus, Rovner interviews Andy Slavitt, who this week launched a health care advocacy group called “The United States of Care.”

Feb. 9, 2018

As States Target High Drug Prices, Pharma Targets State Lawmakers

In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits.

By Jay Hancock and Shefali Luthra

Feb. 1, 2018

Podcast: KHN’s ‘What The Health?’ The State Of The (Health) Union

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo and Julie Appleby and Sarah Jane Tribble of Kaiser Health News discuss President Donald Trump’s promises to reduce drug prices in his first State of the Union Address. The panelists also discuss the departure of the director of the Centers for Disease Control and Prevention after conflict-of-interest reports and the efforts by some states to flout the Affordable Care Act.

Jan. 31, 2018

Expert Advice For The Corporate Titans Taking On Health Care

Amazon, Berkshire Hathaway and JPMorgan Chase & Co. are partnering up to address employee health care costs and improve satisfaction. Can they deliver? And would repackaging health insurance involve drones?

By KFF Health News Staff

Jan. 31, 2018

States Face Costly Conundrum: How To Treat Inmates With Hepatitis C

Although the potentially fatal disease is common among the incarcerated, treatment with the latest hepatitis drugs isn't.

By Alex Smith, KCUR

Jan. 23, 2018

Podcast: What The Health? Our First Live Show: What The Health Will Happen In 2018?

In this episode of “What The Health?” — taped before a live audience — panelists discuss the potential federal government shutdown and what may be in store for health in 2018. They are joined by former Medicare and Medicaid head Tom Scully.

Jan. 18, 2018

Fallout From ‘Nuclear Button’ Tweets: Sales Of Anti-Radiation Drug Skyrocket

Orders for potassium iodide reportedly jumped after a Jan. 2 war of words between Trump and North Korea’s Kim Jong-un.

By JoNel Aleccia

Jan. 11, 2018

Facebook Live: It’s 2018, Can Big Pharma Hold The Line Against Pricing Controls?

In this chat, KHN senior correspondent Jay Hancock discusses how drug-pricing battles could play out this year in D.C., state legislatures and beyond. What do we know about the drug industry’s agenda to quiet the drumbeat of cost control and transparency proposals? How will they officials target their efforts? Will the battles take place at the state level? Senior editor Stephanie Stapleton moderates.

Jan. 10, 2018

HHS Nominee Vows To Tackle High Drug Costs, Despite His Ties To Industry

Alex M. Azar II, the former president of the U.S. division of Eli Lilly, says the U.S. drug system encourages price increases — but he intends to work on that problem.

By Emmarie Huetteman

Jan. 9, 2018

From Retirement To The Front Lines Of Hepatitis C Treatment

This doctor came out of retirement with the goal of treating every patient at high risk for hepatitis C he encounters. The problem is finding them.

By Julio Ochoa, WUSF

Jan. 5, 2018

Letters to the Editor

Readers Have Bones To Pick, From Health System Flaws To Covering Pot Beat

Kaiser Health News gives readers a chance to comment on a recent batch of stories.

Jan. 5, 2018

The Orphan Drug Machine

FDA Chief Says He’s Open To Rethinking Incentives On Orphan Drugs

The FDA’s Scott Gottlieb says the agency is focused on the big picture, and he wants to know why pharma churns out drugs for some rare diseases but not for others.

By Sarah Jane Tribble

Dec. 22, 2017

Arthritis Drugs Show How U.S. Drug Prices Defy Economics

Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.

By Julie Appleby

Dec. 22, 2017

Biosimilars, Biologics And New Legal Challenges For RA Treatments

As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.

By Julie Appleby

Dec. 22, 2017

Drug Industry Spent Millions To Squelch Talk About High Drug Prices

Last year, the pharma industry’ biggest trade group raised millions to change the conversation about drug pricing.

By Jay Hancock

Dec. 19, 2017

Experts Tell Congress How To Cut Drug Prices. We Give You Some Odds.

Some of the nation’s most influential scientists recommend eight steps to lower drug prices. KHN takes the political temperature and tells you the chances of Congress acting on them.

By Sarah Jane Tribble

Dec. 12, 2017

Cities, Counties and Schools Sidestep FDA Canadian Drug Crackdown, Saving Millions

Medicines are up to 80 percent cheaper north of the border and overseas, so U.S. localities are greasing a pharmaceutical pipeline that the feds warn is illegal and possibly unsafe.

By Phil Galewitz

Dec. 8, 2017

Pace Of U.S. Health Spending Slows In 2016

Dramatic increases in spending that came with the influx of newly insured consumers in 2014 and 2015 appear to be moderating.

By Phil Galewitz

Dec. 6, 2017

Enrollment 2018

Podcast: ‘What The Health?’ Taxes, Medicare And The Year-End Mess

In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post discuss the possible impact of the tax bill on the Medicare program, confirmation hearings for a new secretary of Health and Human Services and the future of the Children’s Health Insurance Program. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.

Nov. 30, 2017